ALTSTATION.IO

International Business Machines Corporation (IBM) Stock Analysis

By Nova Skye | AltStation.io | Updated September 19, 2026

Price

$240.08

Change

+2.59%

Market Cap

$226.19B

Avg Volume

8.9M

Company Overview

IBM is an enterprise technology powerhouse based in Armonk, New York, operating in the Information Technology Services industry. The company generates revenue across four distinct units: Software, Consulting, Infrastructure, and Financing. They sell hybrid cloud platforms, AI software, data streaming systems, servers, and storage to large corporations and government bodies like the UK Ministry of Defence. IBM rounds out its catalog by deploying consulting teams to help enterprise clients modernize legacy applications and implement AI-powered workflows.

IBM operates as an entrenched enterprise player rather than a standalone cloud hyperscaler. Its main advantage is deep integration across complex hybrid cloud environments, backed by in-house commercial financing that funds major client deployments. Instead of competing directly against public cloud giants for standard workloads, IBM partners with them, integrating systems alongside Amazon Web Services, Microsoft, Oracle, SAP, Adobe, and Salesforce. The core challenge is maintaining high software and consulting relevance while operating within the ecosystems of these same massive tech partners.

The company is executing a clear strategic pivot toward enterprise AI and hybrid cloud infrastructure, moving far beyond its 1911 corporate roots. Recent strategic moves highlight this direction, including a collaboration with Arm Holdings to develop dual-architecture hardware for AI workloads and a partnership with three.ws to advance AI-powered 3D agent technology. IBM is also reinforcing open source software supply chains with Lightwell and running operational logistics for defense clients through Team ORION. IBM is actively betting its future on being the essential AI, software, and integration layer across enterprise IT.

Key Financials

Market Cap

$226.19B

Revenue

$69.09B

EBITDA

$16.47B

Gross Margin

58.1%

Profit Margin

15.5%

Revenue Growth

1.1%

Total Cash

$8.13B

Total Debt

$65.27B

Free Cash Flow

$12.05B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

21.32

Forward P/E

18.24

Beta

0.71

52-Week High

$332.46

52-Week Low

$199.19

EPS

$11.26

50-Day Avg

$238.85

200-Day Avg

$261.51

Price/Book

6.57

Technical Analysis

IBM trades at $240.08, 34% of the way from its $197.77 52-week low to its $330.09 high. The stock remains 26.30% below that high but stands 23.02% above the low. Price is 3.80% above the $234.39 20-day moving average, while momentum is positive at 3.66% over five trading days and 2.59% over 20 days. Near-term support sits at $222.06, with resistance at $243.29. The trend has improved, but IBM needs to clear $243.29 to confirm more upside.

Recent News and Developments

IBM and NASA launch lunar AI model

IBM and NASA released an open-source model trained on more than 30 data layers from nine instruments across four missions. The model identified key lunar features up to 23% more accurately than widely used methods. Source: Reuters via MarketScreener

IBM brings Quantum System Two to Switzerland

IBM and Lockheed Martin established a quantum innovation hub at ETH Zurich that will host Switzerland’s first IBM Quantum System Two. IBM will operate the Nighthawk-powered system, with deployment planned by the end of 2026. Source: Lockheed Martin

IBM shares jump 3.38%

IBM closed 3.38% higher on September 9 while the Software and IT Services sector fell 0.76%. The stock outperformed its industry as investors reacted to IBM’s quantum-computing progress and new AI models. Source: TradingKey

Market Sentiment and Analyst Recommendations

Bull Case

IBM has $69.09 billion in revenue and a $226.19 billion market cap, giving investors exposure to a large, established technology business. The analyst consensus is buy across 23 analysts, with a $245.35 target and a bullish-end estimate of $350.00. IBM and NASA’s lunar AI model identified key features up to 23% more accurately than widely used methods, showing that the company’s AI work has practical value. IBM and Lockheed Martin also plan to deploy Switzerland’s first IBM Quantum System Two at ETH Zurich by the end of 2026. The stock’s 3.38% gain on September 9, against a 0.76% decline for the Software and IT Services sector, shows investors are responding to the quantum and AI story. At $240.08, IBM remains 26.30% below its 52-week high, leaving room for recovery if those businesses start contributing more visibly.

Bear Case

Revenue growth is only 1.1%, which is weak for a company trading at 21.32 times earnings. The balance sheet carries $65.27 billion in total debt against just $8.13 billion in cash. That debt load limits flexibility if operating performance weakens or major technology investments take longer to pay off. The $245.35 analyst target is only modestly above the current $240.08 price, so the consensus case does not offer much immediate upside. IBM also remains 26.30% below its 52-week high, showing how much confidence the stock has lost despite recent momentum. Quantum computing may offer upside, but the Evercore argument described that value as unpriced rather than pointing to a formal rating change or a quantified contribution.

What to Watch

The first technical test is $243.29, the 30-day high and near-term resistance level. A failure there would put the $234.39 20-day moving average back in focus, followed by support at $222.06. Investors should track whether five-day momentum of 3.66% and 20-day momentum of 2.59% remain positive. Fundamentally, revenue growth needs to improve from 1.1% to better support a 21.32 P/E. Watch for evidence that the NASA AI model and the expanded Lightwell services produce commercial momentum, because no revenue contribution was provided. Progress toward the planned IBM Quantum System Two deployment at ETH Zurich by the end of 2026 would strengthen the quantum thesis, while delays would weaken it.

Analyst Consensus

BUY

Based on 23 analyst opinions

Low Target

$174.00

Mean Target

$245.35

High Target

$350.00

Earnings and Financial Data

Sector

Technology

Industry

Information Technology Services

Employees

264,300

Earnings & Dividends

Next Earnings

Oct 21, 2026

EPS (Trailing)

$11.26

Dividend Yield

282.0%

Payout Ratio

59.8%

Frequently Asked Questions

Is IBM a good stock to buy?

The recommendation is buy based on 23 analysts, and IBM trades at $240.08. The stock has positive five-day and 20-day momentum, but the consensus target of $245.35 offers limited near-term room above the current price. Takeaway: IBM is a buy, but the valuation case is stronger after a pullback or a confirmed breakout.

What is IBM’s price target?

The analyst target is $245.35, with estimates ranging from $174.00 to $350.00. That wide range shows major disagreement about IBM’s outlook. Takeaway: the consensus target is cautious, while individual forecasts span sharply bearish to strongly bullish outcomes.

Is IBM stock overvalued?

IBM trades at a P/E of 21.32 while revenue growth is 1.1%. The data does not provide an industry comparison, but that combination places pressure on IBM to improve growth. Takeaway: the valuation looks demanding relative to the reported growth rate.

What are IBM’s support and resistance levels?

Near-term support is $222.06, the 30-day low, while resistance is $243.29, the 30-day high. IBM currently trades at $240.08. Takeaway: the stock is close to resistance and well above support.

How far is IBM stock from its 52-week high?

IBM is 26.30% below its $330.09 52-week high and 23.02% above its $197.77 low. It sits 34% of the way from the low to the high. Takeaway: IBM has recovered from its low but remains far below its peak.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated September 19, 2026.